JP2004532246A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532246A5
JP2004532246A5 JP2002591475A JP2002591475A JP2004532246A5 JP 2004532246 A5 JP2004532246 A5 JP 2004532246A5 JP 2002591475 A JP2002591475 A JP 2002591475A JP 2002591475 A JP2002591475 A JP 2002591475A JP 2004532246 A5 JP2004532246 A5 JP 2004532246A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
ethyl
methyl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002591475A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004532246A (ja
Filing date
Publication date
Priority claimed from DE10125145A external-priority patent/DE10125145A1/de
Application filed filed Critical
Publication of JP2004532246A publication Critical patent/JP2004532246A/ja
Publication of JP2004532246A5 publication Critical patent/JP2004532246A5/ja
Pending legal-status Critical Current

Links

JP2002591475A 2001-05-22 2002-05-21 置換されたc−フラン−2−イル−メチルアミン−およびc−チオフェン−2−イル−メチルアミン−誘導体 Pending JP2004532246A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10125145A DE10125145A1 (de) 2001-05-22 2001-05-22 Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate
PCT/EP2002/005542 WO2002094802A1 (de) 2001-05-22 2002-05-21 Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate

Publications (2)

Publication Number Publication Date
JP2004532246A JP2004532246A (ja) 2004-10-21
JP2004532246A5 true JP2004532246A5 (https=) 2009-11-05

Family

ID=7685874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002591475A Pending JP2004532246A (ja) 2001-05-22 2002-05-21 置換されたc−フラン−2−イル−メチルアミン−およびc−チオフェン−2−イル−メチルアミン−誘導体

Country Status (17)

Country Link
US (2) US6878740B2 (https=)
EP (1) EP1392670B1 (https=)
JP (1) JP2004532246A (https=)
AR (1) AR035982A1 (https=)
AT (1) ATE299873T1 (https=)
AU (1) AU2002338989B2 (https=)
CA (1) CA2448038C (https=)
DE (2) DE10125145A1 (https=)
DK (1) DK1392670T3 (https=)
ES (1) ES2242869T3 (https=)
HU (1) HUP0401162A3 (https=)
MX (1) MXPA03010601A (https=)
PE (1) PE20021099A1 (https=)
PL (1) PL367535A1 (https=)
PT (1) PT1392670E (https=)
SI (1) SI1392670T1 (https=)
WO (1) WO2002094802A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) * 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
KR100553398B1 (ko) * 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-c]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
CN102482249B (zh) 2009-07-08 2016-06-08 德米拉(加拿大)公司 用于治疗皮肤病症或疾病状态的tofa类似物
KR20160101928A (ko) * 2013-11-22 2016-08-26 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 흡입 약제
KR101844984B1 (ko) * 2016-05-31 2018-04-03 한림대학교 산학협력단 5원 헤테로사이클릭 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
CN112521357B (zh) * 2020-08-31 2021-10-08 深圳瑞健生物科技有限公司 一种长效低成瘾性hnk衍生物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3816457A (en) * 1973-01-05 1974-06-11 Richardson Merrell Inc Lactamimide derivatives
US3890445A (en) * 1973-01-05 1975-06-17 Richardson Merrell Inc Lactamimide derivatives useful as hypoglycemic agents
WO2001068816A1 (en) 2000-03-13 2001-09-20 Smithkline Beecham Corporation Human histamine h3 gene variant-3
DE10012820A1 (de) * 2000-03-16 2001-09-20 Bayer Ag Substituierte 1-Aryl-cyclopropylmethylamino-1,3,5-triazine
DE10059864A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate

Similar Documents

Publication Publication Date Title
JP6931019B2 (ja) 多発性硬化症を処置するためのs1p受容体モジュレーター
EP1602369B1 (en) Bupropion Metabolites for treating anxiety
CN1104892C (zh) 采用神经保护剂治疗耳鸣的方法
WO2001062341A2 (en) Combination product for the treatment of obesity
WO2012166909A1 (en) Compositions and methods for treating breathing control disorders or diseases
RU2005125284A (ru) Производные 2-пиперидона в качестве агонистов простагландина
JP2010522710A5 (https=)
JP2006510600A (ja) 2−チオヒダントインに由来する化合物及び治療におけるその使用
CN102652135A (zh) 脂肪酸酰胺水解酶的含氮杂环抑制剂
US12064410B2 (en) Compositions and methods for stimulating ventilatory and/or respiratory
JP2004532246A5 (https=)
JP2025036479A (ja) 疼痛、炎症および/または自己免疫の処置または予防における使用のための化合物
TW200808741A (en) 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
JP2006516643A5 (https=)
CN1297431A (zh) 用作多巴胺受体的苯磺酰胺-苯乙胺
CN1617883A (zh) 苯并氮杂环庚三烯化合物的固体盐及其在制备药物化合物中的应用
US20180161290A1 (en) Dosage Regimen of Diaryl Sulfide Derivatives
JP2006501207A5 (https=)
PT823892E (pt) Tetralinas contendo um substituinte fenilo no anel aromatico e seu uso no tratamento de epilepsia, ataque apoplectico e trauma cerebral ou vertebral
US20040241135A1 (en) Therapeutic compositions including bio-availability enhancers
JP2007536318A5 (https=)
US10543187B2 (en) Compositions and methods for stimulating ventilatory and/or respiratory drive
JP2004534014A (ja) 新規な経口全身麻酔薬および代謝抵抗性抗痙攣薬
JP2001513497A (ja) 胃分泌過多および腎損傷の予防作用を有する抗炎症剤の製造のための化合物2−メトキシフェニル−1−メチル−5p−メチルベンゾイル−ピロール−2−アセトアミドアセテートの使用
TW201201814A (en) Treatment of autoimmune diseases